The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Am I right in thinking the Chinese are about to launch a competitor to Bango...hence the recent drop in Bangos SP ?
I am sorry to be so negative but anything owned by China will not flourish..the only beneficiaries are the Chinese.
Like it though ! Have they got some new Covid positive product or service happening ??
£10 SHOULD see me right !!!
I will be happy to get half of the money I have wasted here back. Good science awful management..roll on £10.
Looks like Costain is going to do well out of HS2
Never invest in a company that has the Chinese as owners. The only people that benefit are the Chinese.
Shame that we are all so bruised by our Val experience that we groan when another parent is announced. Yet this is really a very good patent to hold and surely some drug company somewhere is interested.
Yet another good friend just diagnosed with metastatic prostate cancer. The need is there for effective treatment.
Beware of any company in which the Chinese have a large interest. I have seen other promising shares go down the gurgler as soon as they took over.
I think my husband..owner of these shares...thinks that they must be worth considerably more than whoever is buying them wants known. Interesting to see what happens tomorrow.
My sad experience of AIM shares with Chinese involvement has been that the only winner is the Chinese. It seems unbelievable that this share could plummet ...there is a rat somewhere.
Is there a fund for helping JG ?? What happened to him ?
That is a more positive message. Desperation is having a beneficial effect ! Now...will it translate into a deal ???
My word..if Satu said that someone improved to that extent, then that to me is significant. They must be worth funding now...and since they are nearly out of cash they must be very willing to accept a reasonable offer. I do understand all the fed up gloomy posters..but Val 201 is still looking good ....probably at greatly increased dosage.
It is very good news....but will it do anything for we unfortunate shareholders. Hopefully it will spur someone with financial clout into doing a deal because I really do believe that the right dose ...could be 10x what they were trialling ..is going to have a very useful effect. And that must be worth big bucks.
I presume the board will just let the company go broke and then buy it up for a few shillings and sell some of the products off. What happened to Val 401 ? I thought that was certain to keep the business afloat till 201 was marketable...
I presume the board will just let the company go broke and then buy it up for a few shillings and sell some of the products off. What happened to Val 401 ? I thought that was certain to keep the business afloat till 201 was marketable...
I like this slow creep upwards. Wish I hadnt sold some last year..!
Intriguing that 201 is grouped with dasatinib. I take a TKI called imatinib for my GIST cancer...it isn't curative but it keeps it at bay. Huge market for TKIs...perhaps one day....
I have just emailed the company at info@bacanora...asking what is going on...the SP is going from bad to very considerably worse...they must surely owe us some explanantion. All I can do is try......